|
1. FDA green-lights J&J immune disorder drug Full story
2. Tariffs stall US investment: Pfizer CEO Full story
3. Speed, value, adoption — how 3 health systems made ambient AI work at scale here.
4. CVS Caremark selects Wegovy as preferred GLP-1 for commercial formularies Full story
5. FDA's chief inspector abruptly resigns Full story
6. Rent risk, tax exposure, balance sheet drag. This smarter real estate strategy is fixing all 3 here.
7. 6 drugs in shortage Full story
8. FDA OKs gene therapy for skin condition Full story
Becker's Learning Opportunities
9. Outdated Rx sourcing is draining health system budgets. What top leaders are doing differently: here.
10. OhioHealth is driving OR efficiency wins. Their clinical leaders share details — here.
11. 82% of infusion centers struggle to use their own data. Why (and what to do about it) here.
|
.png)
